Found 18 results
Filters: Author is Brosius, Frank C  [Clear All Filters]
2017
Korte EA, Caster DJ, Barati MT, Tan M, Zheng S, Berthier CC, Brosius FC, Vieyra MB, Sheehan RM, Kosiewicz M et al..  2017.  ABIN1 Determines Severity of Glomerulonephritis via Activation of Intrinsic Glomerular Inflammation.. Am J Pathol. 187(12):2799-2810.
Hinder LM, Park M, Rumora AE, Hur J, Eichinger F, Pennathur S, Kretzler M, Brosius FC, Feldman EL.  2017.  Comparative RNA-Seq transcriptome analyses reveal distinct metabolic pathways in diabetic nerve and kidney disease.. J Cell Mol Med. 21(9):2140-2152.
O'Brien PD, Hinder LM, Parlee SD, Hayes JM, Backus C, Zhang H, Ma L, Sakowski SA, Brosius FC, Feldman EL.  2017.  Dual CCR2/CCR5 antagonist treatment attenuates adipose inflammation, but not microvascular complications in ob/ob mice.. Diabetes Obes Metab. 19(10):1468-1472.
Zhang H, Nair V, Saha J, Atkins KB, Hodgin JB, Saunders TL, Myers MG, Werner T, Kretzler M, Brosius FC.  2017.  Podocyte-specific JAK2 overexpression worsens diabetic kidney disease in mice.. Kidney Int. 92(4):909-921.
2016
Brosius FC, Tuttle KR, Kretzler M.  2016.  JAK inhibition in the treatment of diabetic kidney disease.. Diabetologia. 59(8):1624-7.
Sas KM, Kayampilly P, Byun J, Nair V, Hinder LM, Hur J, Zhang H, Lin C, Qi NR, Michailidis G et al..  2016.  Tissue-specific metabolic reprogramming drives nutrient flux in diabetic complications.. JCI Insight. 1(15):e86976.
Hur J, O'Brien PD, Nair V, Hinder LM, McGregor BA, Jagadish HV, Kretzler M, Brosius FC, Feldman EL.  2016.  Transcriptional networks of murine diabetic peripheral neuropathy and nephropathy: common and distinct gene expression patterns.. Diabetologia. 59(6):1297-306.
2015
Brosius FC, He JCijiang.  2015.  JAK inhibition and progressive kidney disease.. Curr Opin Nephrol Hypertens. 24(1):88-95.
Atkins KB, Seki Y, Saha J, Eichinger F, Charron MJ, Brosius FC.  2015.  Maintenance of GLUT4 expression in smooth muscle prevents hypertension-induced changes in vascular reactivity.. Physiol Rep. 3(2)
Hur J, Dauch JR, Hinder LM, Hayes JM, Backus C, Pennathur S, Kretzler M, Brosius FC, Feldman EL.  2015.  The Metabolic Syndrome and Microvascular Complications in a Murine Model of Type 2 Diabetes.. Diabetes. 64(9):3294-304.
Lai JY, Luo J, O'Connor C, Jing X, Nair V, Ju W, Randolph A, Ben-Dov IZ, Matar RN, Briskin D et al..  2015.  MicroRNA-21 in glomerular injury.. J Am Soc Nephrol. 26(4):805-16.
Sas KM, Nair V, Byun J, Kayampilly P, Zhang H, Saha J, Brosius FC, Kretzler M, Pennathur S.  2015.  Targeted Lipidomic and Transcriptomic Analysis Identifies Dysregulated Renal Ceramide Metabolism in a Mouse Model of Diabetic Kidney Disease.. J Proteomics Bioinform. Suppl 14
Ju W, Nair V, Smith S, Zhu L, Shedden K, Song PXK, Mariani LH, Eichinger FH, Berthier CC, Randolph A et al..  2015.  Tissue transcriptome-driven identification of epidermal growth factor as a chronic kidney disease biomarker.. Sci Transl Med. 7(316):316ra193.
2014
Brosius FC, Coward RJ.  2014.  Podocytes, signaling pathways, and vascular factors in diabetic kidney disease.. Adv Chronic Kidney Dis. 21(3):304-10.
2013
Brosius FC, Pennathur S.  2013.  How to find a prognostic biomarker for progressive diabetic nephropathy.. Kidney Int. 83(6):996-8.
Hodgin JB, Nair V, Zhang H, Randolph A, Harris RC, Nelson RG, E Weil J, Cavalcoli JD, Patel JM, Brosius FC et al..  2013.  Identification of cross-species shared transcriptional networks of diabetic nephropathy in human and mouse glomeruli.. Diabetes. 62(1):299-308.
Brosius FC, Alpers CE.  2013.  New targets for treatment of diabetic nephropathy: what we have learned from animal models.. Curr Opin Nephrol Hypertens. 22(1):17-25.
2012
Komorowsky CV, Brosius FC, Pennathur S, Kretzler M.  2012.  Perspectives on systems biology applications in diabetic kidney disease.. J Cardiovasc Transl Res. 5(4):491-508.